Synergic activity of fluoroquinolones and linezolid against Mycobacterium tuberculosis See

Nasopharyngeal Microbiota in Children With Invasive Pneumococcal Disease: Identification of Bacteria With Potential Disease-Promoting and Protective Effects See

Criteria of time and antibiotic susceptibility in the elimination of duplicates when calculating resistance frequencies See

In vitro activity of new fluoroquinolones and linezolid against nontuberculous mycobacteria See

Sputum microbiota in moderate versus severe patients with COPD See

In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis See

Real-Time PCR for Diagnosing Helicobacter pylori Infection in Patients with Upper Gastrointestinal Bleeding: Comparison with Other Classical Diagnostic Methods See

Adoption of new technologies in laboratory workflow practices for positive blood culture bottles: a cross-sectional survey among hospitals in the Autonomous Community of Valencia, Spain See

Nasopharyngeal Microbiota as an early severity biomarker in COVID-19 hospitalised patients See